Complex endovascular procedures can result in higher radiation doses for both the patient and the caregiver, with variation based on several different parameters.
As we continue preparing to meet with investors, strategic partners and companies in 2018, we have successfully completed a fifth preclinical study to evaluate our surgical navigation system, IOPS.
Preclinical study update: Jan 2, 2018 Endovascular navigation startup demonstrates use of navigation system Cleveland, Ohio: As Centerline Biomedical, Inc. prepares to meet with investors, strategic partners and companies in the…
From October 23-25, Centerline attended the 15th Annual Medical Innovation Summit hosted by Cleveland Clinic Innovations. This year’s conference was centered around genomics, precision medicine and market-ready technologies that will advance patient care.
On Wednesday, October 18th, Centerline Biomedical was featured at the CVilleBioHub forum on medical devices. Speakers highlighted recent advances in the medical device sector, specifically touching on guidance systems for therapeutic purposes and navigation during procedures.
From September 25th-27th, Centerline attended the MedTech Conference, powered by AdvaMed, in San Jose, California. This conference offered us an opportunity to connect with thousands of medical technology professionals and the investing community.
There has undoubtedly been evidence of physician and patient radiation exposure during an endovascular procedure, but what exactly do the statistics look like?
Our IOPS device is well on its way to market entry! Beginning this fall, we’ll be attending various 2017 medical device conferences and events.